<- Go Home
Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Market Cap
CAD 67.8M
Volume
64.7K
Cash and Equivalents
CAD 13.0M
EBITDA
CAD 5.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CAD 15.4M
Profit Margin
60.61%
52 Week High
CAD 0.52
52 Week Low
CAD 0.29
Dividend
N/A
Price / Book Value
2.39
Price / Earnings
19.42
Price / Tangible Book Value
2.81
Enterprise Value
CAD 61.2M
Enterprise Value / EBITDA
11.38
Operating Income
CAD 3.9M
Return on Equity
13.30%
Return on Assets
6.62
Cash and Short Term Investments
CAD 13.0M
Debt
CAD 6.4M
Equity
CAD 28.3M
Revenue
CAD 25.4M
Unlevered FCF
CAD 1.3M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium